Chief of Psychiatry, Massachusetts General Hospital

President and Executive Director, MGH Mood and Anxiety Disorders Institute

Professor of Psychiatry, Harvard Medical School

Dr. Rosenbaum is recognized as one of the world's foremost authorities on mood and anxiety disorders, with a special emphasis on pharmacotherapy. Dr. Rosenbaum's clinical and consulting practice specializes in treatment-resistant mood and anxiety disorders, and he consults extensively to colleagues on management of these conditions.

His research contributions include extensive participation in the design and conduct of clinical trials of new therapies and innovative treatments, and studies of longitudinal course and outcomes of anxiety disorders.

Dr. Rosenbaum has been an ADAA member since 1989.